An improved method for the detection of hepatitis C virus RNA in plasma utilizing heminested primers and internal control RNA.

PubWeight™: 0.89‹?›

🔗 View Article (PMID 7680265)

Published in PCR Methods Appl on February 01, 1993

Authors

P P Ulrich1, J M Romeo, L J Daniel, G N Vyas

Author Affiliations

1: Department of Laboratory Medicine, University of California, San Francisco 94143-0134.

Articles by these authors

Hemagglutination assay for antigen and antibody associated with viral hepatitis. Science (1970) 5.81

Biology of hepatitis B virus. Science (1981) 4.93

A new rapid method for genetic typing of human immunoglobulins. J Immunol (1968) 2.61

Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization. JAMA (1985) 2.48

Anaphylactoid transfusion reactions associated with anti-IgA. Lancet (1968) 2.40

State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases. Proc Natl Acad Sci U S A (1981) 2.37

Partial amino acid sequence of two major component polypeptides of hepatitis B surface antigen. Proc Natl Acad Sci U S A (1977) 2.34

Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts. Proc Natl Acad Sci U S A (1994) 2.14

Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA (1987) 2.08

Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells. N Engl J Med (1991) 1.95

Enzymatic amplification of hepatitis B virus DNA in serum compared with infectivity testing in chimpanzees. J Infect Dis (1989) 1.88

Hepatitis-associated Australia antigen. Protein, peptides and amine acid composition of purified antigen with its use in determining sensitivity of the hemagglutination test. J Immunol (1972) 1.83

Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant. Proc Natl Acad Sci U S A (1982) 1.81

Australia antigen (hepatitis B antigen): a conformational antigen dependent on disulfide bonds. Science (1972) 1.72

Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase. J Clin Invest (1990) 1.70

Hepatitis B "immune" globulin: effectiveness in prevention of dialysis-associated hepatitis. N Engl J Med (1975) 1.66

Immune response to hepatitis B surface antigen. Infect Immun (1975) 1.59

Asymmetric replication of hepatitis B virus DNA in human liver: demonstration of cytoplasmic minus-strand DNA by blot analyses and in situ hybridization. Virology (1984) 1.48

Molecular pathogenesis of hepatitis B virus infection: simultaneous detection of viral DNA and antigens in paraffin-embedded liver sections. Lancet (1984) 1.42

Resolution of infection status of human immunodeficiency virus (HIV)-seroindeterminate donors and high-risk seronegative individuals with polymerase chain reaction and virus culture: absence of persistent silent HIV type 1 infection in a high-prevalence area. Transfusion (1992) 1.40

Reduction of human immunodeficiency virus-infected cells from donor blood by leukocyte filtration. Transfusion (1989) 1.38

Detection of hepatitis B virus DNA in hepatocytes, bile duct epithelium, and vascular elements by in situ hybridization. Proc Natl Acad Sci U S A (1983) 1.37

Assessment of human immunodeficiency virus expression in cocultures of peripheral blood mononuclear cells from healthy seropositive subjects. J Med Virol (1988) 1.32

Serologic specificity of hun anti-IgA and its significance in transfusion. Blood (1969) 1.30

Molecular characterization of a new variant of hepatitis B virus in a persistently infected homosexual man. Hepatology (1990) 1.28

Polymerase chain reaction compared with concurrent viral cultures for rapid identification of human immunodeficiency virus infection among high-risk infants and children. J Pediatr (1989) 1.28

A precore-defective mutant of hepatitis B virus associated with e antigen-negative chronic liver disease. J Med Virol (1990) 1.27

Cloning of the gene for myxobacterial hemagglutinin and isolation and analysis of structural gene mutations. J Bacteriol (1987) 1.16

A comparative study of hepatitis B viral markers in the family members of Asian and non-Asian patients with hepatitis B surface antigen-positive hepatocellular carcinoma and with chronic hepatitis B infection. J Infect Dis (1979) 1.15

A transcriptional map of the bacteriophage SPO1 genome. III. A region of early and middle promoters (the gene 28 region). Virology (1981) 1.12

Am(1), the first genetic marker of human immunoglobulin A. Proc Natl Acad Sci U S A (1969) 1.12

Biochemical characterization of hepatitis B surface antigen in relation to serologic activity. J Biol Stand (1976) 1.10

Hepatitis B virus DNA in the serum of Sardinian blood donors negative for the hepatitis B surface antigen. Blood (1989) 1.05

Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis (1978) 1.05

Specificity of enzyme immunoassay for hepatitis B core antibody used in screening blood donors. Transfusion (1987) 1.04

Human antibodies to human IgA globulins. Immunochemistry (1968) 1.04

Nucleotide sequence of the myxobacterial hemagglutinin gene contains four homologous domains. Proc Natl Acad Sci U S A (1986) 1.03

Hepatitis B antigen activity in protein subunits produced by sonicaation. Nat New Biol (1973) 1.02

The occurrence of a transmethylation reaction not involving S-adenosylmethionine in the formation of ribothymidine in Bacillus subtilis transfer-RNA. Biochem Biophys Res Commun (1974) 1.01

Isoimmune anti-IgA causing anaphylactoid transfusion reactions. N Engl J Med (1969) 1.01

Studies on delayed hypersensitivity to hepatitis B antigen in chimpanzees. Clin Exp Immunol (1974) 1.01

Biosynthesis of ribothymidine in the transfer RNA of Streptococcus faecalis and Bacillus subtilis. A methylation of RNA involving 5,10-methylenetetrahydrofolate. J Biol Chem (1976) 1.01

Non-A, non-B hepatitis: a contemporary assessment. Haematologia (Budap) (1982) 0.99

T-cell dependence of immune response to hepatitis B antigen in mice. Nature (1975) 0.99

Isoantibodies to human IgM: serologic and immunochemical investigations. J Immunol (1971) 0.96

Comparative data on the detection of hepatitis-B surface antigen by six centres. Indian J Med Res (1981) 0.96

Analysis of hepatitis C virus RNA prevalence and surrogate markers of infection among seropositive voluntary blood donors. Hepatology (1993) 0.95

Evidence against recessive inheritance of susceptibility to the chronic carrier state for hepatitis B antigen. Nature (1974) 0.95

Use of polymerase chain reaction for the early detection of HIV infection in the infants of HIV-seropositive women. AIDS (1991) 0.93

Passive haemagglutination test for anti-rhinovirus antibodies. Nat New Biol (1971) 0.93

Hepatitis B immune globulin: final report of a controlled, multicenter trial of efficacy in prevention of dialysis-associated hepatitis. J Infect Dis (1978) 0.92

Healthy blood donors with selective absence of immunoglobulin A: prevention of anaphylactic transfusion reactions caused by antibodies to IgA. J Lab Clin Med (1975) 0.91

Detection of hepatitis B virus in plasma using flow cytometric analyses of polymerase chain reaction-amplified DNA incorporating digoxigenin-11-dUTP. Blood (1993) 0.90

Letter: Nonspecificity of hepatitis B antigen detected with iodine-125-labeled antibody. Science (1973) 0.90

Hepatitis B viral nucleotide sequences in non-A, non-B or hepatitis B virus-related chronic liver disease. Hepatology (1984) 0.89

Antibodies to IGA in pregnancy and in recipient of Rh o (D) immune globulin (human). Transfusion (1973) 0.89

Early detection of antibodies against rDNA-produced HIV proteins with a flow cytometric assay. Blood (1989) 0.88

Role of platelet-activating factor in hemodynamic derangements in an acute rodent pancreatic model. Gastroenterology (1992) 0.88

Transcription and replication of human immunodeficiency virus-1 in B lymphocytes in vitro. AIDS (1988) 0.88

Intrauterine isoimmunization caused by maternal IgA crossing the placenta. Nature (1970) 0.88

A simple inexpensive method for demonstrating in vitro leukocyte migration. Vox Sang (1973) 0.87

Letter: Anti-IgA in blood donors. Transfusion (1976) 0.87

The molecular biology of hepatitis B virus. Trends Genet (1989) 0.85

The biosynthesis of the methyl groups of choline in Ochromonas malhamensis. Arch Biochem Biophys (1966) 0.85

Evidence for clustering of hepatitis B virus infection in families of patients with primary hepatocellular carcinoma. Cancer (1979) 0.84

Hepatitis B "e" antigen: an apparent association with lactate dehydrogenase isozyme-5. Science (1977) 0.84

Characterization of the interaction between polymerized human albumin and hepatitis B surface antigen. Gastroenterology (1981) 0.84

Flow cytometric immunodetection of human immunodeficiency virus type 1 proviral DNA by heminested PCR and digoxigenin-labeled probes. Clin Diagn Lab Immunol (1994) 0.83

Evolutionary dissociation of gamma G2 and Gm (n) antigens. Vox Sang (1969) 0.83

Activity of a phage-modified RNA polymerase at hybrid promoters. Effects of substituting thymine for hydroxymethyluracil in a phage SP01 middle promoter. J Mol Biol (1986) 0.82

In situ hybridization and immunocytochemistry for improved assessment of human immunodeficiency virus cultures. Am J Clin Pathol (1987) 0.82

In vitro transfer of cell-mediated immunity to hepatitis B antigen with RNA. Nature (1974) 0.82

Structure and activity of hepatitis B antigen (HBAg). 1. Studies on some conformational aspects and chemical modification of hepatitis B antigen. Microbios (1974) 0.82

Interactions between polymerized human albumin, hepatitis B surface antigen, and complement: I. Binding of polyalbumin to Clq. J Med Virol (1981) 0.81

Application of forensic toxicology to the problem of domestic violence. J Forensic Sci (1991) 0.81

Antibody to hepatitis B core antigen in chronic hepatitis and primary biliary cirrhosis: evaluation by a new autologous solid phase radioimmunoassay. Gastroenterology (1977) 0.81

Human antibodies to ruminant IgM concealing the absence of IgA in man. J Lab Clin Med (1971) 0.81

Dual reduction in the immunologic and infectious complications of transfusion by filtration/removal of leukocytes from donor blood soon after collection. Transfus Med Rev (1990) 0.80

A sensitive test for antibody against the hepatitis B core antigen (anti-HB-c). Vox Sang (1975) 0.79

Diagnosis of viral hepatitis. Clin Lab Med (1987) 0.79

Evaluation of leukocyte removal filters modelled by use of HIV-infected cells and DNA amplification. Blood (1990) 0.79

Aflatoxin B1 formamidopyrimidine adducts in human hepatocarcinogenesis: a preliminary report. Gastroenterology (1989) 0.78

Interactions between polymerized human albumin, hepatitis B surface antigen, and complement: II. Involvement of Clq in or near the hepatitis B surface antigen receptor for polyalbumin. J Med Virol (1981) 0.78

Hepatitis B virus infection. Current concepts of chronicity and immunity. West J Med (1984) 0.78

Experimental study of aldomet-induced positive antiglobulin reaction. I. Br J Haematol (1969) 0.78

Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan. J Natl Cancer Inst (1981) 0.78

Laboratory diagnosis of hepatitis B virus infection by nucleic acid hybridization analyses and immunohistologic detection of gene products. Dev Biol Stand (1985) 0.78

Mutations in the S-gene affecting the immunologic determinants of the envelope protein of hepatitis B virus. J Hepatol (1991) 0.78

The phage SPO1-specific RNA polymerase, E.gp28, recognizes its cognate promoters in thymine-containing DNA. Virology (1986) 0.77

Inactivation and removal of blood-borne viruses. Transfusion (1995) 0.77

Nonspecific test reaction for antibodies to hepatitis B surface antigen in chronic HBAg carriers. J Lab Clin Med (1977) 0.77

Hepatitis B virus in non-hepatocytes. Lancet (1983) 0.76

A new virus specified determinant of hepatitis B surface antigen. Acta Pathol Microbiol Scand B (1975) 0.76

Magnesium-mediated reversal of the apparent virucidal effect of ascorbic acid or congo red reacted in vitro with the human immunodeficiency virus. Biologicals (1996) 0.76

Internal medicine-epitomes of progress: immunodiagnosis of viral hepatitis. West J Med (1980) 0.76

A transcriptional map of the bacteriophage SP01 genome: II. The major early transcription units. Virology (1981) 0.76

Comparison of counterelectrophoresis and hemagglutination inhibition tests for hepatitis-associated antigen. Vox Sang (1972) 0.76